Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 1,091 | 854 | 950 | 0 | 796 |
| Gross Profit | 1,091 | 854 | 950 | 0 | 796 |
| Operating Expenses | 15,989 | 13,247 | 12,815 | 10,862 | 7,753 |
| Operating Income | -14,898 | -12,394 | -11,865 | -10,862 | -6,957 |
| Other Income | 297 | 324 | 170 | 168 | -9 |
| Pre-tax Income | -14,601 | -12,069 | -11,695 | -10,694 | -6,966 |
| Net Income Continuous | -14,601 | -12,069 | -11,695 | -10,694 | -6,966 |
| Net Income | $-14,601 | $-12,069 | $-11,695 | $-10,694 | $-6,966 |
| EPS Basic Total Ops | -7.81 | -6.31 | -6.31 | -6.01 | -4.20 |
| EPS Basic Continuous Ops | -7.66 | -6.34 | -6.23 | -6.04 | -4.17 |
| EPS Diluted Total Ops | -7.81 | -6.31 | -6.31 | -6.01 | -4.20 |
| EPS Diluted Continuous Ops | -7.66 | -6.34 | -6.23 | -6.04 | -4.17 |
| EBITDA(a) | $-14,766 | $-12,603 | $-11,449 | $-10,797 | $-6,830 |